Call for Proposals

Coming Calls for Proposals

A call for K.G. Jebsen Centres for Medical Research will be announced in 2021. Dates will be published as soon as the decisions have been made.

Earlier Call for Proposals

2019 – K.G. Jebsen Centres for Medical Research, see text below:

The Kristian Gerhard Jebsen Foundation hereby calls for proposals for funding for new K.G. Jebsen Centres for Medical Research at Norwegian medical faculties and university hospitals.

The new centers will form part of the foundation’s programme for translational medicine. The programme currently comprises 20 research centers established in close cooperation with the medical faculties and university hospitals in Oslo, Bergen, Trondheim and Tromsø.

Full text of call for proposals.


Research Plan Template (download)
Budget Template (download)

Deadline for applications was May 6th 2019.  Funding was awarded to K.G. Jebsen Centre for Alzheimer’s Desease at NTNU and K.G. Jebsen Center for Neurodevelopmental Disorders at UiO.

Evaluation of the KG Jebsen centres initiative 2014 and 2018

The Foundation’s Program of Translational Medicine was evaluated in 2018 by professor Bente Klarlund Pedersen (Rigshospitalet / Københavns universitet), professor emeritus Olli Jänne (University of Helsinki) and professor Mats Benner (Lunds Universitet). The main question was whether the funding scheme is working as intended; is it making a positive difference for Norwegian translational medical research? Is the programme contributing to raising this research to a high international level?
There were no calls for applications in that year. Read the evaluation report here: Evaluation Report on the Program of Translational Medicine Sponsored by Stiftelsen Kristian Gerhard Jebsen

The Foundation’s focus on translational medicine was evaluated in 2014 by Mats Benner (Lund University) and Lars Terenius (Karolinska Institutet). There were no calls for applications in that year. Read the evaluation report here: Evaluation of the Kristian Gerhard Jebsen Foundation’s Support of Translational Medicine